DOC PREVIEW
UIC PCOL 425 - ACE Inhibitors

This preview shows page 1-2-3-24-25-26 out of 26 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 26 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

Slide 1ACE InhibitorsSlide 3Some Biologically Active PeptidesScheme of Peptide Hormone Processing & MetabolismStrategies for Developing Therapeutic AgentsUse of Peptides as DrugsSlide 8Slide 9Slide 10Slide 11Structure of Human Angiotensin Converting Enzyme (ACE)Slide 13Slide 14Mechanism of Action of ACE InhibitorsMechanism of Action of ACE Inhibitors IISlide 17Slide 18Clinical Use of ACE InhibitorsSide Effects/ContraindicationsSlide 21Drug InteractionsAdditional Beneficial Effects of ACE InhibitorsNovel and Unexpected Functions of ACE and ACE inhibitorsSlide 25Other antihypertensive drugs that interfere with the Renin-Angiotensin SystemRandal A. SkidgelRandal A. SkidgelACE InhibitorsFrom: Skidgel and Erdös, AHA Hypertension Primer, 2008ACE InhibitorsACE = Angiotensin I Converting Enzyme10 ACE inhibitors available in US:benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril and trandolapril. ACE inhibitors were the 4th most prescribed drug class in the U.S (159.8 million Rx in 2008).Lisinopril was the 2nd most prescribed drug in the US (75.5 million Rx in 2008).The Renin-Angiotensin and Kallikrein-Kinin SystemsFrom: Skidgel RA and Erdös EG, Hypertension Primer, 4th Edition, Chap. A15, 2008.Some Biologically Active PeptidesACTHACTHAdrenomedullinAdrenomedullinß-Amyloid(1-40)ß-Amyloid(1-40)Anaphylatoxins Anaphylatoxins Angiotensin II Angiotensin II Angiotensin(1-7) Angiotensin(1-7) Atrial Natriuretic Peptide Atrial Natriuretic Peptide BAM-12P, 18P & 22PBAM-12P, 18P & 22PBombesinBombesinBradykinin Bradykinin Brain Natriuretic PeptidesBrain Natriuretic PeptidesBuccalinBuccalinBursin Bursin C-Type Natriuretic Peptide C-Type Natriuretic Peptide Caerulein Caerulein Calcitonin Calcitonin Calcitonin Gene RelatedPeptideCalcitonin Gene RelatedPeptideCardiodilatinCardiodilatinCarnosineCarnosineCASH (Cortical Androgen- Stimulating CASH (Cortical Androgen- Stimulating Hormone)Hormone)CasomorphinsCasomorphinsCerebellinCerebellinCholecystokinin Cholecystokinin ChromostatinChromostatinCLIPCLIPContraceptive TetrapeptideContraceptive TetrapeptideCorticotropin Inhibiting PeptideCorticotropin Inhibiting PeptideCorticostatinCorticostatinCorticotropin ReleasingFactor Corticotropin ReleasingFactor CytokinesCytokinesDelta Sleep-Inducing PeptideDelta Sleep-Inducing PeptideDermorphin Dermorphin Dermaseptin Dermaseptin Diabetes-Associated PeptideDiabetes-Associated PeptideDiazepam Binding Inhibitor Diazepam Binding Inhibitor Dynorphins Dynorphins ß Endorphin ß Endorphin Endothelins Endothelins Met‑Enkephalin Met‑Enkephalin Leu‑Enkephalin Leu‑Enkephalin Epidermal Mitosis Inhibiting Peptide Epidermal Mitosis Inhibiting Peptide ErythropoietinErythropoietinFollicle Stimulating Hormone Follicle Stimulating Hormone GalaninGalaninGastric Inhibitory Polypeptide Gastric Inhibitory Polypeptide Gastrin Gastrin Gastrin-Releasing PeptideGastrin-Releasing Peptideα-Gliadorphinα-GliadorphinGranuliberin-RGranuliberin-RGlucagon Glucagon Glucagon-Like PeptideGlucagon-Like PeptideGrowth Factors Growth Factors Growth HormoneGrowth HormoneGrowth Hormone‑ ReleasingHormone Growth Hormone‑ ReleasingHormone GuanylinGuanylinInhibin Inhibin Insulin Insulin InterleukinsInterleukinsKallidin Kallidin KyotorphinKyotorphinα & ß-Lactorphinα & ß-LactorphinLeucokinins Leucokinins LipotropinLipotropinLuteinizing Hormone (LH)Luteinizing Hormone (LH)LH‑Releasing HormoneLH‑Releasing HormoneMagaininsMagaininsMastoparanMastoparanMelanin-ConcentratingMelanin-Concentrating HormoneHormoneα‑Melanocyte Stimulatingα‑Melanocyte Stimulating Hormone Hormone MelanostatinMelanostatinMorphine ModulatingMorphine Modulating NeuropeptideNeuropeptideMotilinMotilinα‑Neoendorphinα‑Neoendorphinß‑Neoendorphinß‑NeoendorphinNeurokinin ANeurokinin ANeurokinin BNeurokinin BNeuromedin NNeuromedin NNeuropeptide YNeuropeptide YNeuropeptide PNeuropeptide Pß-Neuroprotectinß-NeuroprotectinNeurotensinNeurotensinNeutrophil DefensinsNeutrophil DefensinsOrexinsOrexinsOxytocinOxytocinPACAP (Pituitary Adenylate Cyclase Activating PACAP (Pituitary Adenylate Cyclase Activating Peptide)Peptide)PancreastatinPancreastatinPancreatic PolypeptidePancreatic PolypeptideParathyroid HormoneParathyroid HormonePeptide Histidine IsoleucinePeptide Histidine IsoleucinePeptide YYPeptide YYProlactinProlactinProctolinProctolinRiginRiginSecretinSecretinSomatostatinSomatostatinSubstance PSubstance PSysteminSysteminThymosinThymosinThyrotropinThyrotropinThyrotropin ReleasingThyrotropin Releasing HormoneHormoneTuftsinTuftsinUrocortinUrocortinUroguanylinUroguanylinVasopressin (ADH)Vasopressin (ADH)VIP (Vasoactive IntestinalVIP (Vasoactive Intestinal Peptide)Peptide)ProhormonePeptidase 1RK RREndoproteaseActive PeptideProcessing EnzymeReceptor 1Receptor 2Peptidase 2 Scheme of Peptide Hormone Processing & MetabolismStrategies for Developing Therapeutic AgentsPeptidase 1Active PeptideReceptor 1Receptor 2Peptidase 2Administer the PeptideUse of Peptides as DrugsAdvantagesHighly potent/excellent specificityWide variety of Biological ActivitiesStraightforward SynthesisPredictable ChemistryLittle or no toxicity from metabolismDisadvantagesOral administration difficult because of:Degradation by digestive enzymes and intestinal peptidasesPoor absorption across tight junctions in epithelila Efflux systems may pump absorbed peptides back outInconvenient administration Rapidly cleaved by peptidasesExcreted by kidneyRelatively expensive to synthesize compared with small organic moleculesPeptidase 1Receptor 1Receptor 2Peptidase 2 Block Degradation by PeptidasesStrategies for Developing Therapeutic AgentsStrategies for Developing Therapeutic AgentsPeptidase 1Active PeptideReceptor 1Receptor 2Peptidase 2Use a Receptor AntagonistProhormonePeptidase 1RK RREndoproteaseActive PeptideProcessing EnzymeReceptor 1Receptor 2Peptidase 2Block Synthesis/ProcessingStrategies for Developing Therapeutic AgentsACEACE DISTRIBUTION Widespread, concentrated on:•Endothelial surface of the vasculature•Epithelial Brush borders•Renal proximal tubules•Small intestine•Placenta•Choroid plexusStructure of Human Angiotensin Converting Enzyme (ACE)ACEACEC-domainN-domainA given peptidase can


View Full Document

UIC PCOL 425 - ACE Inhibitors

Documents in this Course
Exam 3

Exam 3

7 pages

Kozasa

Kozasa

14 pages

Load more
Download ACE Inhibitors
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view ACE Inhibitors and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view ACE Inhibitors 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?